|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.14/1.00
|
企業價值
44.21M
|
資產負債 |
每股賬面淨值
7.08
|
現金流量 |
現金流量率
--
|
損益表 |
收益
1.28M
|
每股收益
1.08
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/02 22:36 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. |